Abstract
Full text available
Current Drug Targets
Title: Aiming at New Targets for the Treatment of Affective Disorders: An Introduction
Volume: 10 Issue: 11
Author(s): Eliyahu Dremencov
Affiliation:
Abstract: Full text available
Export Options
About this article
Cite this article as:
Dremencov Eliyahu, Aiming at New Targets for the Treatment of Affective Disorders: An Introduction, Current Drug Targets 2009; 10 (11) . https://dx.doi.org/10.2174/138945009789735110
DOI https://dx.doi.org/10.2174/138945009789735110 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Phytoestrogens: Pharmacological and Therapeutic Perspectives
Current Drug Targets Psychosocial Vulnerability and Early Life Adversity as Risk Factors for Central Sensitivity Syndromes
Current Rheumatology Reviews The Chemistry and Bio-Medicinal Significance of Pyrimidines & Condensed Pyrimidines
Current Topics in Medicinal Chemistry Substance Use Portrayal in Oscar-nominated Movies
Current Drug Research Reviews Opioid Withdrawal Syndrome: Emerging Concepts and Novel Therapeutic Targets
CNS & Neurological Disorders - Drug Targets Growth Restriction: Etiology, Maternal and Neonatal Outcome. A Review
Current Women`s Health Reviews Rebalancing the Oral Microbiota as an Efficient Tool in Endocrine, Metabolic and Immune Disorders
Endocrine, Metabolic & Immune Disorders - Drug Targets The Future of Diabetes Management by Healthy Probiotic Microorganisms
Current Diabetes Reviews Neurotransmitter and Imaging Studies in Anorexia Nervosa: New Targets for Treatment
Current Drug Targets - CNS & Neurological Disorders Editorial (Thematic Issues: Pharmacological Intervention for Down Syndrome Cognitive Deficits: Emerging Drug Targets)
CNS & Neurological Disorders - Drug Targets Editorial [Hot Topic:Metalloproteinases Revisited (Guest Editor: Marcia L. Moss)]
Current Pharmaceutical Biotechnology Gadolinium-based Imaging Contrast Agents
Current Medical Imaging The Therapeutic Potential of Novel Kappa Opioid Receptor-based Treatments
Current Medicinal Chemistry Update of QSAR & Docking & Alignment Studies of the DNA Polymerase Inhibitors
Current Bioinformatics Evaluation of Cytotoxic and Tyrosinase Inhibitory Activities of 2-phenoxy(thiomethyl) pyridotriazolopyrimidines: In Vitro and Molecular Docking Studies
Anti-Cancer Agents in Medicinal Chemistry Selective Hydrogenation of Aromatic Chloronitro Compounds
Current Organic Chemistry Cefepime-Induced Neurotoxicity
Central Nervous System Agents in Medicinal Chemistry Small Molecules in Stem Cell Research
Current Pharmaceutical Biotechnology Surface Modified Self-Nanoemulsifying Formulations (SNEFs) For Oral Delivery of Gentamicin: In Vivo Toxicological and Pre- Clinical Chemistry Evaluations
Current Nanomedicine An Updated Patent Review on Ocular Drug Delivery Systems with Potential for Commercial Viability
Recent Patents on Drug Delivery & Formulation